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Neonatal abstinence syndrome (NAS) has become an increasing, problematic, and concerning 
phenomenon in the United States.1 NAS is a collection of withdrawal signs and symptoms experienced 
by neonates due to exposure in utero to illicit substances. The incidence has increased 3-fold in the past 
decade. Substances most often correlated with NAS include opiates, barbiturates, cocaine, caffeine, 
antihistamines, benzodiazepines, nicotine, marijuana, and benzodiazepines.2 
Signs and Symptoms of Neonatal Withdrawal 
Some symptoms of withdrawal may consist of high-pitched or excessive crying, increased muscle tone, 
poor feeding, jitteriness, skin excoriation, increased respiratory rate, and nasal flaring. Other symptoms 
that may be experienced include poor temperature regulation, mottling, vomiting, loose or watery 
stools, and, in extreme cases, seizures. Low birth weight and premature birth are also correlated 
findings of intrauterine substance exposure.2 The Table presents a summary of newborn withdrawal 
symptoms. Initial withdrawal symptoms will present within the first 2 weeks of life. 
The literature has shown that between 54% and 90% of infants born of substance-dependent mothers 
will experience NAS.2 Recognition of NAS early in the newborn’s life is important to reduce the duration 
of NAS symptoms, length of hospital stays, and lifelong sequelae. Literature supports the importance of 
early recognition and appropriate nursing care. An analysis of 547 infants with NAS demonstrated the 
importance of providing appropriate, evidence-based care to improve patient outcomes. 
There are short- and long-term consequences due to NAS. Short-term consequences include symptoms 
of withdrawal. Appropriate referrals during the withdrawal period include occupational therapy and 
social services. These referrals are initiated most commonly during hospitalization. Long-term 
consequences of NAS include physical, mental, and psychological challenges that can produce lifelong 
disability. Early diagnosis and early intervention can reduce developmental delays in newborns with 
NAS.3 
An instrument used to objectively assess and score the signs and symptoms of NAS is the Finnegan 
Neonatal Abstinence Scoring Tool (FNAST).4 The FNAST provides a method for similar assessments 
between examiners and may be used for serial assessments to identify improvement or worsening of 
the infant’s condition. In addition, FNAST may be used in both inpatient and outpatient settings to assist 
with NAS diagnosis. Limited information has been published on the FNAST’s validity, but its reliability 
has been identified between examiners. 
Additional comorbidities to consider in the event of NAS include neonatal exposures to sexually 
transmitted infections or intravenous drug use such as syphilis, chlamydia, gonorrhea, HIV, hepatitis B, 
and hepatitis C. Breast-feeding is not contraindicated unless the mother is HIV-positive status or 
continues to use illicit substances. Delayed motor development at 1 year of age has been noted in 
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breast-fed infants whose mothers continue to smoke marijuana or consume alcohol.2 Overall treatment 
of infants who suffer from NAS is largely supportive. When medications are prescribed to wean 
neonates from substances, specialist knowledgeable in substance abuse and NAS treatment should 
develop individualized treatment plans. 
Conclusion 
As maternal substance abuse increases, the incidence of NAS will continue to rise. It is pertinent to 
implement evidence-based practice nursing care for these infants, which includes early diagnosis, 
referral, and interventions. Assessing all newborns for NAS initially during hospitalization, and then again 
at the initial well-child exam improves opportunity for timely diagnosis. Nurse practitioners in primary 
care settings have the opportunity to work with all childbearing-aged females, including those currently 
pregnant, to promote prevention, recognition, and appropriate treatment of maternal substance abuse. 
Table. Neonatal Abstinence Syndrome Signs During First 2 Weeks of Life 
Excessive or high-pitched crying 
Poor sleep 
Hyperactive newborn reflexes 
Tremors 
Increased muscle tone 
Myoclonic jerking 
Seizures 
Sweating 
Vomiting 
Frequent yawning 
Skin mottling 
Nasal stuffiness 
Sneezing 
Tachypnea 
Excessive suckling 
Poor feeding 
Vomiting 
Loose stools 
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